Relationship between sleep disorders and the efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer

Among older NSCLC patients receiving ICI treatment, sleep disorders are significantly associated with poorer treatment efficacy and a higher risk of multisystem adverse reactions. The findings of this study provide preliminary evidence for integrating sleep assessment into individualized ICI treatment strategies in this population.